Organon (NYSE: OGN) reported Q4 EPS of $0.88, $0.09 better than the analyst estimate of $0.79. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.56 billion.

GUIDANCE:

Organon sees Q1 2024 revenue of $6.2-6.5 billion, versus the consensus of $6.396 billion.

For earnings history and earnings-related data on Organon (OGN) click here.